Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
SEC Accession No. 0001213900-26-003903
Filing Date
2026-01-13
Accepted
2026-01-13 16:01:34
Documents
4
Group Members
CRYSTAL PEAK HOLDINGS INC.CRYSTAL PEAK INVESTMENT INC.DAVE LIGUANG CHENNHUAQIN XUEOCEANPINE CAPITAL INC.OCEANPINE INVESTMENT FUND II LPOCEANPINE MERGER SUB INC.OCEANPINE SKYLINE INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13E-3 ea0272699-sc13e3a2_lake.htm SC 13E3/A 223423
2 PRELIMINARY PROXY STATEMENT OF THE COMPANY DATED JANUARY 13, 2026 (THE "PROXY ST ea027269901ex99-a1_lake.htm EX-99.(A)(1) 1739695
3 GRAPHIC exa-1_001.jpg GRAPHIC 4009
4 GRAPHIC exa-1_002.jpg GRAPHIC 3232
  Complete submission text file 0001213900-26-003903.txt   1975972
Mailing Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629
Business Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629 17327133678
LakeShore Biopharma Co., Ltd. (Filed by) CIK: 0001946399 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13E3/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629
Business Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629 17327133678
LakeShore Biopharma Co., Ltd. (Subject) CIK: 0001946399 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13E3/A | Act: 34 | File No.: 005-94412 | Film No.: 26530062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)